pankajmathur/National_Library_of_Medicine_Studies_data huggingface dataset:
Clinical trial: An Observational Study on the Efficacy of Individualised Homoeopathic Treatment on Premenstrual Syndrome
Status: COMPLETED
Conditions: Premenstrual Syndrome
Interventions: OTHER: Individualised Homeopathic Remedy
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients
Status: COMPLETED
Conditions: Hypoglycemia|Complications of Bariatric Procedures
Interventions: DRUG: G-Pump™ (glucagon infusion)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Evolut PRO China Clinical Study
Status: ACTIVE_NOT_RECRUITING
Conditions: Severe, Symptomatic Aortic Stenosis
Interventions: DEVICE: Medtronic CoreValve™ Evolut™ PRO System
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: An Adjunct Test Distinguishing Bacterial From Viral Etiology Improves Resource Utilization and Efficiency in the ED.
Status: RECRUITING
Conditions: Respiratory Tract Infections
Interventions: DIAGNOSTIC_TEST: MeMed BV® biomarker test|DIAGNOSTIC_TEST: Usual care
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: DIAGNOSTIC
Clinical trial: Lifestyle Modification for Obesity-Related Type 2 Diabetes
Status: COMPLETED
Conditions: Type 2 Diabetes Mellitus|Overweight|Obesity
Interventions: BEHAVIORAL: Low carbohydrate, ketogenic diet|BEHAVIORAL: Low glycemic index, reduced calorie diet
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Histological Segmentation of the Superficial Femoral Artery From Microscan to CT Using Artificial Intelligence
Status: NOT_YET_RECRUITING
Conditions: Peripheral Artery Disease|Femoropopliteal Stenosis
Interventions: PROCEDURE: Endovascular surgery
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Rosuvastatin for Preventing Deep Vein Thrombosis
Status: UNKNOWN
Conditions: Deep Vein Thrombosis|Venous|Thrombosis|Prevention
Interventions: DRUG: Rosuvastatin 20mg/d for 14days|DRUG: enoxaparin only
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: A Study to Understand the Effects of Carbamazepine on How Vepdegestrant is Processed in Healthy Participants
Status: COMPLETED
Conditions: Healthy Participants
Interventions: DRUG: Vepdegestrant|DRUG: Carbamazepine
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Online Peer-Delivered 1-Day CBT Workshops for PPD
Status: COMPLETED
Conditions: Postpartum Depression
Interventions: BEHAVIORAL: Online Peer-Delivered 1-Day CBT-Based Workshop
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Opioid Free Anesthesia vs. Opioid Anesthesia Techniques.
Status: UNKNOWN
Conditions: Analgesic Drug Dependence|Colectomy
Interventions: DRUG: Opioid Anesthesia|DRUG: Opioid-free Anesthesia
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION
Clinical trial: HEAVy HAT-HEAlthy Volunteers Heart to Arm Time. Haemorrhage Simulation Protocol in Healthy Volunteers
Status: COMPLETED
Conditions: Shock
Interventions: DEVICE: LBNP Lower Bodi Negative Pressure Chamber
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Pharmacokinetic Profile and Pharmacodynamic Characteristics of a Furosemide High Dosage Formulation in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis
Status: COMPLETED
Conditions: Renal Failure
Interventions: DRUG: FUROSEMIDE|DRUG: FUROSEMIDE (HOE058)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Relative Bioavailability and Food Effect Study
Status: COMPLETED
Conditions: Pharmacology, Clinical
Interventions: DRUG: Riociguat (BAY63-2521)|DRUG: Riociguat (BAY63-2521)|DRUG: Riociguat (BAY63-2521)|DRUG: Riociguat (BAY63-2521)|DRUG: Riociguat (BAY63-2521)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose:
Clinical trial: Recolonization Following Preoperative Disinfection Plastic Adhesive Drapes
Status: COMPLETED
Conditions: Surgical Wound Infection
Interventions: OTHER: Plastic adesive drape|OTHER: Microbial Sealant
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION
Clinical trial: Research on Key Technologies and System Optimization of Early Warning and Resuscitation of Cardiac Arrest
Status: RECRUITING
Conditions: Emergencies
Interventions: PROCEDURE: Aortic balloon assisted resuscitation|PROCEDURE: Traditional cardiopulmonary resuscitation|PROCEDURE: Esophageal cooling|PROCEDURE: traditional cooling
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects
Status: COMPLETED
Conditions: HIV Infections|Protease Inhibitor
Interventions: DRUG: Atazanavir Sulphate + Ritonavir|DRUG: Atazanavir Sulphate + Ritonavir + Efavirenz
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose:
Clinical trial: Identification of Biometric Marker(s) Capable of Detecting Early Prediabetes: Clinical Trial 1
Status: COMPLETED
Conditions: Healthy
Interventions: OTHER: Standardized liquid test meal|DRUG: Atropine + Standardized liquid test meal
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Cementation Techniques; an In-vitro Study
Status: COMPLETED
Conditions: Cementation Teeth; Hyperplasia|Dental Cements|Tooth Crown Fracture
Interventions: OTHER: Cementation Technique A|OTHER: Cementation Technique B|OTHER: Cementation Technique C
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: OTHER
Clinical trial: Study to Evaluate the Effectiveness, Safety and Long Term Safety of Saypha® FILLER Lidocaine for Lip Augmentation
Status: COMPLETED
Conditions: Abnormal Lip
Interventions: COMBINATION_PRODUCT: Saypha® FILLER Lidocaine (HQ)|COMBINATION_PRODUCT: Saypha® FILLER Lidocaine (C1)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection
Status: RECRUITING
Conditions: Cystic Fibrosis Lung|Respiratory Infections, Recurrent, Chronic|Pseudomonas Aeruginosa
Interventions: DRUG: RSP-1502|DRUG: Tobramycin inhalation solution
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Participants With Early Stage Triple Negative Breast Cancer
Status: COMPLETED
Conditions: Breast Cancer
Interventions: DRUG: Ipatasertib|DRUG: Paclitaxel|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Tele-Electrocardiography in Emergency Cardiac Care
Status: COMPLETED
Conditions: Myocardial Infarction|Chest Pain
Interventions: DEVICE: Electrocardiogram (ECG) Intervention|OTHER: Routine Clinical Practice
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU
Status: TERMINATED
Conditions: Uveitis Posterior Non-Infectious|Uveitis, Intermediate|Noninfectious Panuveitis
Interventions: DRUG: ESK-001
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effects of a Cognitive Rehabilitation Program: a Neurocognitive Study
Status: COMPLETED
Conditions: Schizophrenia
Interventions: BEHAVIORAL: Computer-assisted cognitive training|OTHER: Computerized active condition|OTHER: Treatment as usual (TAU)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.
Status: COMPLETED
Conditions: Invasive Pneumococcal Disease
Interventions: DRUG: Pneumococcal 7-valent conjugate vaccine Prevnar
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia
Status: COMPLETED
Conditions: Type 2 Diabetes|Stroke|Myocardial Infarction
Interventions: DRUG: glucagon-like-peptide-1|DRUG: placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Using Practice Facilitation in Primary Care Settings to Reduce Risk Factors for Cardiovascular Disease
Status: COMPLETED
Conditions: Cardiovascular Disease|High Blood Pressure
Interventions: BEHAVIORAL: Million Hearts ABCS 6 Months|BEHAVIORAL: Million Hearts ABCS 9 Months|BEHAVIORAL: Million Hearts ABCS 12 Months|BEHAVIORAL: Million Hearts ABCS 15 Months|BEHAVIORAL: Standard Care Regimen 9 Months|BEHAVIORAL: Standard Care Regimen 12 Months|BEHAVIORAL: Standard Care Regimen 15 Months|BEHAVIORAL: Standard Care Regimen 18 Months|BEHAVIORAL: Standard Care Regimen 21 Months|BEHAVIORAL: Standard Care Regimen 24 Months|BEHAVIORAL: Standard Care Regimen 27 Months|BEHAVIORAL: Follow Up Post Intervention 21 Months|BEHAVIORAL: Follow Up Post Intervention 24 Months|BEHAVIORAL: Follow Up Post Intervention 27 Months|BEHAVIORAL: Follow Up Post Intervention 30 Months|BEHAVIORAL: Follow Up Post Intervention 33 Months
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Artemether-lumefantrine vs Chloroquine for Uncomplicated P. Vivax Malaria in Malaysia
Status: UNKNOWN
Conditions: Plasmodium Vivax Malaria Without Complication
Interventions: DRUG: Artemether-lumefantrine + Primaquine|DRUG: Chloroquine + Primaquine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma
Status: ACTIVE_NOT_RECRUITING
Conditions: Extraocular Retinoblastoma
Interventions: PROCEDURE: Autologous Bone Marrow Transplantation|PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation|DRUG: Carboplatin|DRUG: Cisplatin|DRUG: Cyclophosphamide|DRUG: Etoposide|BIOLOGICAL: Filgrastim|PROCEDURE: In Vitro-Treated Peripheral Blood Stem Cell Transplantation|RADIATION: Radiation Therapy|DRUG: Thiotepa|DRUG: Vincristine Sulfate
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study in Healthy Men to Test How BI 690517 is Taken up and Handled by the Body
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: BI 690517 (C-14)|DRUG: BI 690517
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Efficacy Evaluation of Focused HIFU (High Intensity Focused Ultrasound) Therapy in Patients With Localized Intermediate Risk Prostate Cancer
Status: ACTIVE_NOT_RECRUITING
Conditions: Prostate Cancer
Interventions: PROCEDURE: treatment with focal HIFU|BIOLOGICAL: PSA dosage|DEVICE: MRI|OTHER: Questionnaires|PROCEDURE: Prostatic biopsies|BIOLOGICAL: blood test|BIOLOGICAL: urine test
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Popliteal Approach to Sciatic Nerve Block Is Not Inferior to Infragluteal Approach
Status: COMPLETED
Conditions: Neuromuscular Blockade
Interventions: PROCEDURE: Popliteal approach|PROCEDURE: Infragluteal approach
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Entropy and Surgical Pleth Index Guided Closed Loop Target Controlled Infusion Total Intravenous Anesthesia With Propofol
Status: UNKNOWN
Conditions: Anesthesia Awareness
Interventions: DEVICE: Closed-Loop propofol Target controlled infusion by Entropy and SPI|DEVICE: Open-loop propofol target controlled infusion
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: TAMIS-IPAA vs. Lap-IPAA for Ulcerative Colitiis
Status: UNKNOWN
Conditions: Ulcerative Colitis|Postoperative Complications|Ileal Pouch
Interventions: PROCEDURE: TAMIS-IPAA|PROCEDURE: Lap-IPAA
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Intrabone Infusion of Umbilical Cord Blood Stem Cells
Status: COMPLETED
Conditions: Hematopoietic Stem Cell Transplantation
Interventions: PROCEDURE: Intrabone infusion of umbilical cord blood stem cells
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effectiveness of Dry Needling vs Manual Therapy in Patients With Temporomandibular Joint Disorders.
Status: COMPLETED
Conditions: Temporomandibular Joint Disorders|Dry Needling|Musculoskeletal Manipulations
Interventions: OTHER: Dry needling|OTHER: Manual Therapy Treatment
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients
Status: RECRUITING
Conditions: Cervical Cancer
Interventions: DRUG: adjuvant concurrent chemoradiotherapy|RADIATION: radiotherapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: BI 425809|DRUG: BI 425809|DRUG: Placebo|DRUG: BI 425809
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Clinical trial: Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19
Status: UNKNOWN
Conditions: ARDS Related to Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 2|Acute Refractory Heart Failure Related to SARS-CoV 2
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Prospective Observation for Serial Changes of Acute Intracranial Artery Dissection Using High Resolution MRI
Status: UNKNOWN
Conditions: Cerebral Arterial Diseases|Dissecting Aneurysm of Cerebral Artery|Intimal Dissection
Interventions: OTHER: High resolution magnetic resonance imaging for intracranial vessel walls
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer Therapy
Status: COMPLETED
Conditions: Ovarian Cancer
Interventions: DRUG: Hycamtin|DRUG: Gemcitabine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: NeuroAiD II™ (MLC901) in Mild Traumatic Brain Injury
Status: COMPLETED
Conditions: Traumatic Brain Injury
Interventions: COMBINATION_PRODUCT: Traditional Chinese Medicine (NeuroAiD II™ (MLC901)|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Cervical Ripening as an Outpatient Method Using the Foley (COMFORT)
Status: RECRUITING
Conditions: Induction of Labor Affected Fetus / Newborn
Interventions: DEVICE: Outpatient Foley catheter
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Treating Depression With Transcranial Direct Current Stimulation (tDCS)
Status: COMPLETED
Conditions: Depression
Interventions: DEVICE: transcranial direct current stimulation|DEVICE: transcranial direct current stimulation|DEVICE: transcranial direct current stimulation|DEVICE: iomed phoresor transcranial direct current stimulation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Theta-burst rTMS in Schizophrenia to Ameliorate Negative and Cognitive Symptoms
Status: ENROLLING_BY_INVITATION
Conditions: Transcranial Magnetic Stimulation Repetitive|Schizophrenia
Interventions: DEVICE: repetitive Transcranial Magnetic Stimulation (rTMS)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Modulating Effects of Oil Palm Phenolics in Subjects With Pre-diabetes
Status: WITHDRAWN
Conditions: Prediabetes
Interventions: DIETARY_SUPPLEMENT: Oil Palm Phenolics|DIETARY_SUPPLEMENT: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Assessment of a New Protocol for Indirect Pulp Capping Procedures
Status: UNKNOWN
Conditions: Reversible Pulpitis
Interventions: DEVICE: Mechanical rotary burs|DEVICE: Carisolv gel
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma
Status: TERMINATED
Conditions: Metastatic Melanoma|Skin Cancer
Interventions: DRUG: Cyclophosphamide|DRUG: Fludarabine|BIOLOGICAL: Tumor Infiltrating Lymphocytes|DRUG: IL-15
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Adolescents
Status: COMPLETED
Conditions: Influenza
Interventions: BIOLOGICAL: split-virion pandemic influenza vaccine (H5N1 strain NIBRG-14)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy
Status: ACTIVE_NOT_RECRUITING
Conditions: Recurrent Glioblastoma
Interventions: DRUG: Carboplatin|DEVICE: Exablate BBBD
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists
Status: COMPLETED
Conditions: Eczema|Dermatitis|Dermatitis, Atopic|Genetic Disease, Inborn|Hypersensitivity|Hypersensitivity, Immediate|Immune System Diseases|Skin Diseases|Skin Diseases, Eczematous|Skin Diseases, Genetic
Interventions: OTHER: Care provided by general pediatrician|OTHER: Care provided by pediatric dermatologist
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.
Status: COMPLETED
Conditions: Relapsed Multiple Myeloma|Refractory Multiple Myeloma
Interventions: DRUG: Dexamethasone|DRUG: Daratumumab|DRUG: Carfilzomib
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Intrathecal Atropine Versus Intravenous Ondasetron in Post Operative Nausea Due to Intrathecal Morphine
Status: UNKNOWN
Conditions: Perineal Surgery
Interventions: DRUG: Ondansetron , atropine and bupivacaine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Influence of a Bitter Compound and Bittermasking Compound on Gastric pH
Status: UNKNOWN
Conditions: Change of Gastric pH
Interventions: OTHER: water|DIETARY_SUPPLEMENT: caffeine|DIETARY_SUPPLEMENT: caffein + homoeriodictyol sodium salt|DIETARY_SUPPLEMENT: homoeriodictyol sodium salt
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Radiesse® Injectable Dermal Filler for the Treatment of Nasolabial Folds in Persons of Color
Status: COMPLETED
Conditions: Nasolabial Folds
Interventions: DEVICE: Radiesse® Injectable Dermal Filler
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy
Status: COMPLETED
Conditions: Prostate Cancer
Interventions: DRUG: Docetaxel
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Spinal Cord Stimulation and Autonomic Response in People With SCI.
Status: UNKNOWN
Conditions: Spinal Cord Injuries|Autonomic Dysreflexia|Orthostatic Hypotension, Dysautonomic
Interventions: DEVICE: Epidural spinal cord stimulation|DEVICE: Trnascutaneous electrical spinal cord stimulation.
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Yoga and Diet on Cognitive, Nutritional Status, Mental and Functional Abilities in Older Adults
Status: COMPLETED
Conditions: Aging
Interventions: OTHER: Yoga and Mediterranean Diet intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Milrinone in Addition to Hyperdynamic Therapy in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage
Status: TERMINATED
Conditions: Cerebral Vasospasm
Interventions: DRUG: Milrinone|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: The Effect of G-DBT on the Patients With BN : A Multicenter Randomized Controlled Study
Status: COMPLETED
Conditions: Feeding and Eating Disorders
Interventions: BEHAVIORAL: Dialectical Behavioral Group Therapy|DRUG: Drug: fluoxetine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Study of the Relationship Between Feeding and Late Onset Sepsis and/or Necrotizing Enterocolitis in Low Birth Weight Infants
Status: COMPLETED
Conditions: Necrotizing Enterocolitis|Sepsis
Interventions: BEHAVIORAL: Fortified Pasteurized Donor Human Milk supplement|BEHAVIORAL: Preterm Formula supplement
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: |Masking: DOUBLE|Primary Purpose: TREATMENT
Clinical trial: Babies Living Safe and Smokefree
Status: COMPLETED
Conditions: Second Hand Tobacco Smoke|Nicotine Dependence
Interventions: BEHAVIORAL: Ask, Advise, Refer|BEHAVIORAL: Telebased tobacco counseling|BEHAVIORAL: Telebased nutrition counseling|DEVICE: Mobile phone smoking cessation application|DEVICE: Mobile phone nutrition application|DRUG: Nicotine polacrilex
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer
Status: COMPLETED
Conditions: Superficial Bladder Cancer
Interventions: BIOLOGICAL: BC-819/PEI
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Fruquintinib With mFOLFOX6/FOLFIRI as First-Line Therapy for Conversion Surgery in mCRC
Status: RECRUITING
Conditions: Colorectal Cancer
Interventions: DRUG: Fruquintinib+mFOLFOX6/FOLFIRI
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Integrated Dose Escalation for Advanced, Localized Gynecologic Cancer (The IDEAL - GYN Trial)
Status: COMPLETED
Conditions: Cancer of the Cervix|Cervical Neoplasms
Interventions: RADIATION: Boost radiation
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery
Status: SUSPENDED
Conditions: Ovarian Cysts|Endometriosis|Adhesions
Interventions: BIOLOGICAL: ADHEXIL
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Effectiveness of a Novel Concept for a Manual Toothbrush Broscyl®
Status: TERMINATED
Conditions: Healthy Subjects
Interventions: DEVICE: Manual toothbrush reference|PROCEDURE: Measure of the dental plaque|DEVICE: Manual toothbrush Broscyl®
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE|Primary Purpose:
Clinical trial: Oropharyngeal Exercises to Treat Obstructive Sleep Apnea
Status: RECRUITING
Conditions: Obstructive Sleep Apnea
Interventions: BEHAVIORAL: Oropharyngeal Exercises|BEHAVIORAL: Sham Exercises
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Validation Study of Sodium Hyaluronate in Patients With Periarthritis of Shoulder
Status: UNKNOWN
Conditions: Periarthritis
Interventions: DRUG: Sodium Hyaluronate|DRUG: Aerzhi
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease
Status: TERMINATED
Conditions: Alzheimer Disease
Interventions: DRUG: Dimebon 20 mg po TID|DRUG: Placebo po TID
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Combination Tissue Plasminogen Activator (Tpa) and Dornase Alfa (Dnase) Administration Through Intrapleural Catheters for the Treatment of Loculated or Non-Draining Malignant Pleural Effusions
Status: UNKNOWN
Conditions: Loculated or Non-draining Malignant Pleural Effusions
Interventions: DRUG: Combination TISSUE PLASMINOGEN ACTIVATOR (TPA) AND DORNASE ALFA (DNASE)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Effect of SGLT2 Inhibitors on Cognitive Functions and BDNF Levels in Patients With Type 2 Diabetes
Status: TERMINATED
Conditions: Type2 Diabetes|Cognitive Impairment
Interventions: DIAGNOSTIC_TEST: MOCA cognitive evaluation test|DIAGNOSTIC_TEST: BDNF levels|OTHER: SF-36 test|DIAGNOSTIC_TEST: Geriatric depression test
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With NSTEMI or Unstable Angina
Status: RECRUITING
Conditions: Coronary Artery Disease|Coronary Syndrome|Cryotherapy Effect|Myocardial Infarction|Myocardial Disease|Atherosclerosis, Coronary
Interventions: DEVICE: CryoTherapy System (CTS)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DEVICE_FEASIBILITY
Clinical trial: Docosahexaenoic Acid on Breath Holding Spells in Children
Status: RECRUITING
Conditions: Breath Holding Attack
Interventions: DRUG: DHA|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin
Status: RECRUITING
Conditions: Pediatric HIV Infection|Tuberculosis Infection
Interventions: DRUG: rifampicin
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: 3 Airway Clearance Techniques in Non Cystic Fibrosis Bronchiectasis
Status: COMPLETED
Conditions: Bronchiectasis
Interventions: OTHER: Autogenic drainage|OTHER: Slow expiration with glottis opened in lateral posture|OTHER: Temporary-positive expiratory pressure
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine
Status: COMPLETED
Conditions: Hepatitis B, Chronic
Interventions: DRUG: Telbivudine|DRUG: oral adefovir
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Analysis and Reducing Modalities for Artefacts Generated by Bone Conduction Implants and Cochlear Implants Subjected to an MRI Magnetic Field
Status: COMPLETED
Conditions: Hearing Implants|Implant Hearing Artefact
Interventions: DEVICE: Artefact IRM assessment
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Distal Versus Conventional Transradial Artery Access for Coronary Catheterization in Patients With STEMI
Status: RECRUITING
Conditions: ST Elevation Myocardial Infarction|Coronary Artery Disease|Distal Transradial Artery|Transradial Artery|Coronary Catheterization|Percutaneous Coronary Intervention|Primary PCI
Interventions: PROCEDURE: Coronary angiography +/- percutaneous coronary intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Evaluating the Effects of an Oral Protein Supplement on Children's Growth Patterns
Status: COMPLETED
Conditions: Growth Disorders|Dietary Exposure|Child Development|Bone Development Abnormal|Body Weight|Child Malnutrition
Interventions: DIETARY_SUPPLEMENT: TruHeight Growth Protein Shake
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric Cancer
Status: RECRUITING
Conditions: Gastric Cancer
Interventions: DRUG: Lenvatinib 20mg|DRUG: Pembrolizumab|DRUG: Lenvatinib 8mg|DRUG: Docetaxel|DRUG: Oxaliplatin|DRUG: Levofolinate|DRUG: Fluorouracil
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Cardiovascular Function in COPD Patients
Status: COMPLETED
Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: DRUG: Tiotropium|DRUG: Olodaterol|DRUG: Fluticasone propionate|DRUG: Salmeterol
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Trial Comparing Electric and Harmonic Scalpel in Mastectomy
Status: COMPLETED
Conditions: Complication, Postoperative
Interventions: PROCEDURE: Electric scalpel|PROCEDURE: Harmonic scalpel
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Trientine Hydrochloride for the Prevention of Macular Edema Associated With Pan-retinal Photocoagulation for Severe Non-proliferative and Proliferative Diabetic Retinopathy
Status: TERMINATED
Conditions: Diabetic Retinopathy
Interventions: DRUG: Trientine Hydrochloride|DRUG: Oral placebo capsules
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose:
Clinical trial: Group Treatment for PTSD: A Randomized Clinical Trial With Veterans
Status: COMPLETED
Conditions: PTSD
Interventions: BEHAVIORAL: Group Cognitive Behavioral Treatment (GCBT)|BEHAVIORAL: Present Centered Group Treatment
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: The Effect of Telephone Support for Breastfeeding Follow-up on Infantile Colic and Maternal Breastfeeding Self-efficacy
Status: COMPLETED
Conditions: Breastfeeding, Exclusive|Infantile Colic|Self Efficacy|Jaundice, Neonatal
Interventions: OTHER: Telephone support for breastfeeding follow-up
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Partial Maxillary Expansion With Post Grafting Expansion vs. Pre Full Maxillary Expansion in Secondary Alveolar Cleft
Status: NOT_YET_RECRUITING
Conditions: Alveolar Cleft
Interventions: PROCEDURE: pre grafting partial maxillary expansion with post grafting expansion
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID)
Status: UNKNOWN
Conditions: COVID-19 Infection|Cancer Patients|General Population
Interventions: BIOLOGICAL: Convalescent Plasma from COVID-19 donors
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Fasting Study of Cilostazol Tablets 100 mg and Pletal® Tablets 100 mg
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: Cilostazol Tablets 100 mg|DRUG: Pletal® Tablets 100 mg
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer
Status: TERMINATED
Conditions: Breast Neoplasms|Breast Cancer|Breast Tumors|Cancer of the Breast|Neoplasms, Breast|Tumors, Breast
Interventions: DRUG: Eribulin|DRUG: Doxorubicin|DRUG: Cyclophosphamide|DRUG: Pegfilgrastim
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Single-Center Investigator-Initiated Evaluator-Bilateral-Comparison Pilot Study of Injectable Calcium Hydroxylapatite With and Without Triamcinolone Acetate for the Treatment of Volume Loss to Dorsum Areas of the Hands
Status: COMPLETED
Conditions: Volume Loss to Dorsum of Hands
Interventions: OTHER: Calcium Hydroxylapatite and Triamcinolone acetate|DEVICE: Calcium Hydroxylapatite and Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Study of Fruquintinib in Patients With Metastatic Colorectal Cancer
Status: COMPLETED
Conditions: Colorectal Cancer
Interventions: DRUG: fruquintinib|DRUG: placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Building an Evidence Base for Weight Loss Strategies Among Those With Chronic SCI-The GLB-SCI+
Status: UNKNOWN
Conditions: Spinal Cord Injuries|Obesity|Weight Loss|Diet Modification
Interventions: BEHAVIORAL: Portion-Controlled Meals|BEHAVIORAL: Enhanced Self-Monitoring|BEHAVIORAL: GLB-SCI|BEHAVIORAL: GLB-SCI+
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
Status: COMPLETED
Conditions: Stage IIIB Non-Small Cell Lung Cancer|Stage IV Non-Small Cell Lung Cancer
Interventions: DRUG: Paclitaxel|DRUG: Carboplatin|DRUG: STA 4783
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Clinical trial: Effect of Global Postural Re-education in Idiopathic Scoliosis
Status: TERMINATED
Conditions: Idiopathic Scoliosis
Interventions: OTHER: GPR-A|OTHER: GPR-B
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Impact of Orally Administered BPM31510 on Mitochondrial Energetics in Older Adults With Sarcopenia
Status: WITHDRAWN
Conditions: Sarcopenia
Interventions: DRUG: BPM31510|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal Transplantation
Status: UNKNOWN
Conditions: Renal Transplantation
Interventions: DRUG: cyclosporine|DRUG: Everolimus
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Methotrexate Polyglutamate Levels as a Marker for the Clinical Outcome in the Treatment of Rheumatoid Arthritis
Status: COMPLETED
Conditions: Rheumatoid Arthritis
Interventions: DRUG: methotrexate|DRUG: methotrexate
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Balancing Act: Impact on Falls in Older Adults With Vision Impairment
Status: COMPLETED
Conditions: Postural Balance
Interventions: OTHER: Balancing Act exercise curriculum|OTHER: Informational Brochure
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Effects of TEAS on Stress Response During Extubation of General Anesthesia in Elderly Patients
Status: COMPLETED
Conditions: Stress
Interventions: DEVICE: Hwato Electronic Acupuncture Treatment Instrument|DEVICE: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Status: RECRUITING
Conditions: AML|AML With Mutated NPM1|Hematologic Malignancy|KMT2Ar|NPM1 Mutation|MLL Rearrangement|Leukemia|Acute Myeloid Leukemia|Leukemia, Myeloid|Leukemia, Myeloid, Acute|Acute Leukemia|Neoplasms by Histologic Type
Interventions: DRUG: Ziftomenib|DRUG: Fludarabine|DRUG: Idarubicin|DRUG: Cytarabine|DRUG: Gilteritinib|BIOLOGICAL: Granulocyte colony-stimulating factor
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Distal vs Proximal Radial Approach for Coronary Interventions
Status: UNKNOWN
Conditions: Coronary Disease|Vascular Diseases
Interventions: PROCEDURE: coronary angiography using distal radial artery|PROCEDURE: coronary angiography using proximal radial artery
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Prevention of Seroma Formation and Wound Complications Using NPWT Devices
Status: COMPLETED
Conditions: Seroma|Wound Dehiscence|Wound Infection
Interventions: DEVICE: Renasys*GO Negative Pressure Wound Therapy System
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Effects of Amino Acids on Regional Lipid Metabolism
Status: COMPLETED
Conditions: Hypertriglyceridemia
Interventions: DIETARY_SUPPLEMENT: Amino acids|DIETARY_SUPPLEMENT: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas
Status: RECRUITING
Conditions: Soft Tissue Sarcoma Adult
Interventions: OTHER: Blood and tissue collection for immunological studies, advanced imaging.|OTHER: neoadjuvant Therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney Disease
Status: UNKNOWN
Conditions: Diabetic Nephropathies|Hypertension
Interventions: DIETARY_SUPPLEMENT: Standardized salt diet|DRUG: Amiloride
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies
Status: ACTIVE_NOT_RECRUITING
Conditions: Advanced Malignancies|Non-small-cell Lung Cancer
Interventions: DRUG: PF-06801591
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effect of Structured Patient Interviews in the Preoperative Anesthesia Clinic on Recall of Relevant Information
Status: COMPLETED
Conditions: Anesthesia|Surgical Procedure, Unspecified|Communication
Interventions: OTHER: Trained anesthesiogist
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: Tomographic and Histologic Assessment on the Influence of the Use of a Collagen Membrane to Protect the Antrostomy After Maxillary Sinus Floor Augmentation.
Status: COMPLETED
Conditions: Alveolar Bone Loss|Alveolar Bone Resorption
Interventions: PROCEDURE: Maxillary sinus augmentation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Safety and Tolerability Study for Age-Related Macular Degeneration
Status: COMPLETED
Conditions: Neovascular Age-Related Macular Degeneration
Interventions: DRUG: hI-con1™ 60µl|DRUG: hI-con1™ 150µl|DRUG: hI-con1™ 300µl
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study of Icotinib With Chemotherapy as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer
Status: RECRUITING
Conditions: Non-Small Cell Lung Cancer
Interventions: DRUG: Icotinib|DRUG: Cisplatin|DRUG: Carboplatin|DRUG: Pemetrexed
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid Tumors
Status: TERMINATED
Conditions: Solid Tumors, Adult|Multiple Myeloma|Lymphoma
Interventions: DRUG: VP301
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.
Status: TERMINATED
Conditions: Liver Metastases|Colorectal Carcinoma
Interventions: DRUG: Tilmanocept (Technetium Tc 99m tilmanocept Injection)|PROCEDURE: SPECT/CT Imaging
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Kinect Equations for Body Indices and Body Composition
Status: UNKNOWN
Conditions: Anthropometry|Body Composition
Interventions: DIAGNOSTIC_TEST: Microsoft Azure Kinect Developer Kit|DIAGNOSTIC_TEST: Bioelectrical impedance analyzer|DIAGNOSTIC_TEST: Dual Energy X-ray Absorptiometry
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients
Status: WITHDRAWN
Conditions: Peripheral Artery Disease|Vascular Disease|Arterial Occlusion Disease|Intermittent Claudication|Ankle Brachial Index (0.9 or Less)
Interventions: DRUG: Ticagrelor|DRUG: clopidogrel
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
Status: COMPLETED
Conditions: Ulcerative Colitis
Interventions: DRUG: Infliximab 5 mg/kg|DRUG: Infliximab 10 mg/kg|DRUG: Placebo
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E)
Status: TERMINATED
Conditions: Duchenne Muscular Dystrophy
Interventions: DRUG: idebenone 150 mg film-coated tablets
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT